{
    "@graph": [
        {
            "@id": "gnd:124918905",
            "sameAs": "McGuire, Thomas G."
        },
        {
            "@id": "gnd:39157-8",
            "sameAs": "National Bureau of Economic Research"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A1794146814",
            "@type": "bibo:Book",
            "P1053": "1 Online-Ressource",
            "http://purl.org/dc/elements/1.1/creator": "Drake, Keith M.",
            "description": [
                "Campusweiter Zugriff (Universit\u00e4t Hannover) - Vervielf\u00e4ltigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.",
                "illustrations (black and white)"
            ],
            "identifier": [
                "(ppn)1794146814",
                "(doi)10.3386/w29801",
                "(firstid)KEP:076804925"
            ],
            "publisher": "National Bureau of Economic Research",
            "subject": [
                "Konfliktregelung",
                "Patent",
                "(classificationName=linseach:automatic)rest",
                "Generika",
                "Arzneimittel",
                "Markteintritt"
            ],
            "title": "Most-Favored Entry Clauses in Drug Patent Litigation Settlements as a Potential Reverse Payment",
            "abstract": "Settlements of drug patent disputes that involve a potential payment from the brand to the generic signal a possible collusive profit split with a threat to competition, and have undergone intensive scrutiny in the literature on law and economics.  A common feature of these brand-generic settlements, so-called \"most-favored entry\" (MFE) clauses, have not been investigated to the same extent.  The expectation that brand drug companies make settlement decisions rationally implies that an otherwise unexplained brand payment above savings from expected future litigation costs derives from a delay in competition achieved by the settlement.  This paper applies the condition of brand rationality to settlements with MFE clauses, with the added consideration that an MFE clause may affect two dates:  the date of entry for the settling generic and the date of entry of third-party generic challengers.  A brand payment from an MFE clause above future expected litigation costs implies delays in at least one and possibly two of these expected dates for competition.  We find that MFE clauses can constitute a reverse payment.  When a payment takes the form of an MFE clause, the pay-above-saved-litigation-cost criterion is, however, vulnerable to suggesting that a settlement is not anticompetitive, when in fact it is",
            "contributor": "Technische Informationsbibliothek (TIB)",
            "creator": [
                "gnd:124918905",
                "gnd:39157-8"
            ],
            "isPartOf": "(collectioncode)ZDB-194-NBW",
            "issued": "2022",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "open access",
            "medium": "rda:termList/RDACarrierType/1018",
            "volume": "no. w29801",
            "isLike": "doi:10.3386/w29801",
            "P30128": "NBER working paper series",
            "P60163": "Cambridge, Mass"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "volume": "http://purl.org/ontology/bibo/volume",
        "abstract": "http://purl.org/dc/terms/abstract",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "description": "http://purl.org/dc/elements/1.1/description",
        "creator": {
            "@id": "http://purl.org/dc/terms/creator",
            "@type": "@id"
        },
        "issued": "http://purl.org/dc/terms/issued",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "title": "http://purl.org/dc/elements/1.1/title",
        "publisher": "http://purl.org/dc/elements/1.1/publisher",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "P30128": "http://www.rdaregistry.info/Elements/m/#P30128",
        "isLike": {
            "@id": "http://umbel.org/umbel#isLike",
            "@type": "@id"
        },
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "license": "http://purl.org/dc/terms/license",
        "P60163": "http://www.rdaregistry.info/Elements/u/#P60163",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "contributor": "http://purl.org/dc/terms/contributor",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}